Publication | Closed Access

Addition of either irinotecan or methotrexate to bolus5-fluorouracil and high-dose folinic acid every 2 weeks in advanced colorectal carcinoma: a randomised study by the Southern Italy Cooperative Oncology Group

Gastrointestinal OncologyMedicineHigh-dose Folinic AcidPharmacologyColorectal CancerAdvanced Colorectal CarcinomaPharmacotherapyCancer TreatmentOncologyRadiation OncologyCancer Research